or apply directly on Pulmovant's site. We never take the application ourselves.
Is this posting real?
- This role has been open
- 4 days Pulmovant's roles stay open a median of 13 days
- Reposted
- No
- Salary listed
- No 0% of Pulmovant's roles list one
- Ghost-job risk at Pulmovant
- low 0 stale, 0 reposted of 7 open
- Hiring momentum
- 7 roles opened in the last 90 days ↑ up vs. the prior 90 days
- Last confirmed on the employer's board
- 2026-09-28
Measured from postings appearing on and disappearing from Pulmovant's own greenhouse board since 2026-08-03. Full hiring picture for Pulmovant.
About this role
The Director of Biostatistics at Pulmovant will lead biostatistical efforts for the Phase 3 PHrontier program, focusing on the investigational drug mosliciguat for pulmonary hypertension associated with interstitial lung disease. This role involves developing statistical strategies, collaborating with clinical and regulatory teams, overseeing CRO deliverables, and mentoring junior staff, all while ensuring compliance with regulatory standards and quality in trial design and analysis.
- benefits
- 1/5
- freshness
- 5/5
- career value
- 4/5
- role clarity
- 5/5
- pay transparency
- 0/5
Scored from the posting itself — how clearly the role is described, how much it says about pay and benefits, and how recently it was listed. Not a judgement of Pulmovant as an employer.
What you need
- PhD or MS in Biostatistics, Statistics, or related field
- 8+ years of biostatistics experience in clinical drug development
- Direct Phase 3 experience
- Deep expertise in SAS and/or R for clinical trial analysis
- Strong understanding of ICH/FDA statistical guidance and GCP, ICH standards, and CDISC principles
- Experience managing CRO biostatistics relationships
Nice to have
- Prior experience contributing to a regulatory submission (NDA/BLA)
- Pulmonary/respiratory therapeutic area experience
Worth weighing
- No salary listed
- The role requires significant experience in clinical drug development, which may limit applicants without a strong background in this area.
- The position is remote, which may appeal to some candidates but could also mean less in-person collaboration.
- The company is in a clinical-stage, which may involve a fast-paced and potentially high-pressure environment.
Summarised from Pulmovant's posting. Read the full original.
Listed by Pulmovant on their greenhouse job board, last confirmed open on 2026-09-28. PitchMeAI is not the employer.
More roles at Pulmovant
- Senior Manager, Pharmacovigilance, PulmovantRemote, US
- Senior Director, Clinical Development, PulmovantRemote, US
- Director, CMC Quality, PulmovantRemote, US
- Senior Manager, Regulatory Affairs, PulmovantRemote, US
- Director, Clinical Supply, PulmovantRemote, US
- Senior Manager, IT Applications, PulmovantRemote, US